Purchase Order 75F40121P00044
Award Date
12/31/20
Potential Completion Date
12/30/22
Potential Value
$213K
Federal Agency
Food and Drug Administration
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and related products, for the provision of a MiSeq sequencing instrument and a one-year preventative maintenance agreement. The total potential value of this contract is $109,857.00. Illumina has a history of providing sequencing systems and services to support genomic research and diagnostics across various federal...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents, to provide a MiSEQ SYSTEM. The $152,792.00 contract has no set-aside designation. Illumina has previously been awarded prime contracts by other federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Veterans...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $114,681.00 contract is for the delivery of a MiSeq System, a high-throughput next-generation DNA sequencing platform used to support life science research, applied markets, and molecular diagnostics. This award does not have a set-aside designation. Illumina has a history of providing...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $87,870.00 contract is for the provision of a MiSeq DNA sequencing system and related consumables. The award has no set-aside designation. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the National Institutes of Health (NIH), Centers for Disease...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the delivery of 3 Illumina MiSeq sequencing systems. The $284,971.50 contract has an April 30, 2019 completion date and does not use any set-aside provisions. Illumina has a history of providing sequencing equipment and consumables to support genomic research and diagnostics at various federal...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $166,207.78 contract is for the provision of the MiSeq Whole Genome Sequencing Instrument, a genome sequencer, with an ultimate completion date of June 30, 2029. Illumina has previously been awarded prime federal contracts and subcontracts by agencies such as the National Institutes of Health...
The Department of Health and Human Services Food and Drug Administration awarded a $457,531.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of an ILLUMINA NEXTSEQ 2000 SEQUENCING SYSTEM, plus a preventative maintenance agreement, to be performed in Silver Spring, Maryland. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems and related...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order contract to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $98,736.56 contract is for the provision of MISEQ REAGENT KITS to support the agency's genetic and genomic analysis requirements. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the NIH, CDC, USDA, and VA, to supply sequencing...
This federal contract award by the Department of Health and Human Services Food and Drug Administration adds $110,510.96 in funding to an original requisition with Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract is a firm fixed price Delivery Order with no set-aside designation. Illumina has previously provided sequencing systems, consumables, and support services to various government agencies for research and diagnostics. This award likely supports...